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ABNORMAL tissue anitigenis have beeni demoiistrated by direct immuiioclhemicaf
analysis in an umber of human tumours (McKenna, Sanderson and Blakemore,
1964; Tee, Wang and Watkins, 1964) as well as spontaneous (Abramoff, Chinchi-
niian and Saunders, 1959 ; Pontieri, Bianco and Plescia, 1962) and experimeintallv
induced animal tumours (Brondz. 1964; Narcissov and Abelev, 1959). The
largest body of evidence however is that derived from investigations of carciniogen
induced liver tumours. Hence abnormal microsomal antigens have beeni denioii-
strated bv immuniodiffusion methods in both transplanted rat (Deckers. 1964;
Maisin, 1964a) and mouse (Abelev, 1963) hepatomas originallv iinduced with
carcinogenic aminoazo dyes, whilst Hirai, Taga, Isaka, Satoh and Warabioka
(1963) have reported the presence of a soluble, tumour specific antigen in a
rat ascites hepatoma. Pressman and co-workers (Hiramato, Jurand, Bernecky
and Pressman, 1963) have also detected abnormal microsomal antigens in 2-
acetamidofluorene induced rat liver tumours using immunofluorescence techniques
and Tanigaki (1963) using this procedure showed the presence of abnormal cell
surface antigens in a rat ascites hepatoma.
In assessing the significance of cell antigeni chaniges durinig aminioazo dye
carcinogenesis in rat liver, the total changes, includinig both gain and loss, are
being examined. These studies have revealed that a number of normal liver
microsomal and soluble cytoplasmic protein (cell sap) antigenls are deleted from
tumour (Baldwin, 1964). In this communication evidence is presented indicatin-g
that aminoazo dve induced tumours also conitaini abniormal antigens.
MATERIALS AND METHODS
.Ntormal rat liver
Normal liver was takeni from 3-4 month old male rats of an iinbred WN'istar
straini maintained on a standard cubed diet (MR441B) with water ad libituin.
Amtinoazo dye induced liver tumours
Liver tumours were induced bv feeding rats oni 4-dimethylaminoazobeiizenie
(DMAB) at a level of 006 per cent in a low protein diet for 3 months and then on
the basal diet alone for up to 2 months. Histological examination sho-ed that
the tumours could be classified into two main tyTpes, bile duct carcinlomiia and
hepatocellular carcinoma (Baldwin, 1964).
In selecting tissue for anialysis, only well defined, noni-niecrotic tumour iiiasses
were taken. These were removed following perfusion in situ with ice cold saline
anid 0-44 al sucrose, care being taken to exclude gross contaminationi with liver.CELL ANTIGENS OF DMAB TUMOOtURS
Some tumours were transplanted into syngeneic hosts in order to provide larger
amounts of tumour tissue, and these grew in all cases. Againi only non-necrotic
tumours were taken for study and generally, these were from the 2nd to 4th
generation transplants.
Sub-cellular fractionation of tissue
Sub-cellular fractions ofliver or tumour were isolated usinig previously described
methods (Baldwin, 1964). Essentially, tissue samples, thoroughly perfused in
situ with ice cold 0.15 M NaCl and 0 44 M sucrose, were homogenized in 0 44 Mr
sucrose (1 to 2 ml./g. wet weight of tissue) and microsome fractions isolated from
mitochondrial (20,000 g) supernatants by centrifugation at 105,000 g for 120
minutes. The microsome and supernatant (cell sap) fractions were then further
purified by re-centrifugation at 105,000 g for 120 minutes. Unless used immedi-
ately, tihsue fractions were rapidly frozen in alcohol-solid CO2 mixture and stored
at -20) C.
For immuiiochemical analysis, cell sap fractions were used directly without any
further treatment, whilst microsomes were solubilized in 0-4 per cent sodium
deoxycholate at pH 8X0 (Baldwin, 1964). Because of the low yield of tumour
microsomes (I to 2 mg./g. wet weight of tumour) solubilized fractious were not
usuallv sub-fractioniated into soluble protein and ribosomal components.
Preparation oJ antisera
Antigens.-Fractions used as immunizinig antigens were pooled preparations
from a number of primary DMAB-induced liver tumours.
Tumonur cell sap.-Fractions in 0*44 M sucrose containing 8 to 12 mg. protein/ml.
Tuniour mnicrosornes.-Whole microsome fractions re-suspended in 0.25 MN1
suicrose so as to contain 6 to 9 mg. proteini/ml. (microsome yield 1 to 2 mg. protein/g.
wet weight of tumour.
Adult albino rabbits received intramuscular injections at .3 weekly intervals of
tumour fractions (1 ml.) emulsified with an equal volume of Freund's adjuvant
(complete) (Difco). In general, fractions from tumour were less effective than
those from normal liver so that a more prolonged immunization course of 5 to x
iiijections was necessary to produce sufficiently potent antisera.
Rabbits were bled 2 to 3 weeks after the final injection and sera collected.
MIerthiolate was added to a concentration of 001 per cent and antisera were
stored at 200 C.
Jknmunochemnical/ procedures
Double diffusion analyses were carried out in 1 per cent agar gels in buffered
saline (0.15 M NaCl, 0*01 M Na phosphate, pH 7.4) containing 0.2 per cent sodium
azide as preservative. Cell sap fractions were tested directly in 0 44 M sucrose,
whilst solubilized microsome fractions were applied to gels in 0-25 M sucrose
contaiining 0-4 per cent sodium deoxycholate. Diffusion wells were filled once
with 0-2 ml. of each reagent and the sealed plates incubated at 2' C. Under
these conditions, precipitation patterns usually were fully developed within 7 to
10 days.
Immunoelectrophoresis was carried out oni 20 x 12 cm. glass plates coated
with a 2 mm. laver of 1 per cent agar in V'eronail buffer, pH S86; ,p 0-025 (Grabar,
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1959). Electrophoresis was conducted at 2° C. employing a potential gradienit
of 5 volts/cm. for 3 hours. For analysis, tissue fractions were equilibrated with
Veronal buffer, pH 8-6; It 0 05 by dialysis against 50 to 100 volumes of buffer at
2' C. for 20 hours. Any precipitate was removed by centrifugation (3,000 g for
30 minutes) and the solutions mixed with equal volumes of 2 per cent agar in
distilled water for insertion into gel plates. Following electrophoresis, immuno-
diffusion patterns were developed at 2° C. for 7 to 10 days.
RESULTS
Tumour cell sap antigens
Comparison of the agar gel immunodiffusion reaction patterns of normal liver
(Ncs) and tumour (Tcs) cell sap fractions with anti-tumour antiserum (anti-Tcs)
clearly demonstrates that two major tumour antigens do not cross-react with
components in normal liver (Fig. 1, top pattern). Furthermore, these abnormal
tumour antigens do not cross-react with cell sap fractions prepared from apparently
healthy liver taken from tumour-bearing rats (Fig. 1, lower pattern), thus demon-
strating that they arise during tumour induction and not from a non-specific
response during carcinogen administration.
Cell sap fractions from 18 individual DMAB-induced tumours have been
examined and all preparations were found to contain antigens not cross-reacting
with normal liver. Additionally abnormal tumour antigens were detectable in
transplanted tumour. This is illustrated in Fig. 2 which shows the cross-reaction
of cell sap fractions of two transplanted liver tumours (D8/4 and D20/1) and
normal liver with an anti-tumour cell sap antiserum.
In order to confirm that the abnormal components observed in tumour were
niot normal liver antigens present in greatly increased concentration, attempts
were made to remove antibody reacting with these components by pre-absorptioi
of anti-tumour cell sap antiserum with normal liver. Aliquots of antiserum were
inicubated at 40 C. for 4 days with varying amounts of normal liver cell sap, and
after removal of antigen-antibody precipitates by centrifugation (3000 r.p.m.
30 minutes), the absorbed sera were cross-reacted with normal liver and tumour
cell sap fractions. As shown in Table I, absorption with normal liver cell sap at
TABLE I.-Absorption of Anti-Tumour Cell Sap Antiserum
with Normal Liver Cell Sap
Absorption conditions:
amount of normal livei
Numnber of cell sap protein mg./ml.
)recipitation linies antiserurn
formed following -%
reaction with: O) 4 8 16 20
Tumour cell sal) 7 4 3 4 4
(1-3 mg./ml.)
Normal liver cell sap 3 1 O4 1 1
(1*3 mg./mnl.)
a concentration of 8 mg. protein/ml. of antiserum removed all antibody cross-
reacting with this fraction. In contrast absorption with up to 20 mg. normal
liver cell sap/ml. antiserum was without effect on the abniormal precipitation lines
detected followinig reaction with tumour cell gap. The agar gel reaction patterni
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obtainied usinig antiserumi repeatedly absorbed with normal liver cell sap (Fig. 3)
clearly indicates that at least three precipitation lines detectable following reaction
with tumour cell sap do not cross-react with normal liver antigens.
Immunoelectrophoresis of cell sap fractions further facilitated identificatioin of
abnormal tumour antigens, at least seven components being detectable (Fig. 4).
The pattern obtained using antiserum exhaustivelyr absorbed with normal liver
cell sap was not markedly different and at least five components detected followiNng
reactioni with tumour cell sap did not cross-react with normal liver.
Tumour microsontal antiyens
In order to examine cha,nges in microsomal anitigens during IDMAB carciino-
geniesis, rabbit antisera were prepared against whole microsome fractions isolatedl
from pooled primary liver tumours. For immunodiffusion analysis, microsome
fractions were solubilized in 04 per cent sodium deoxycholate and examined
without any fiurther treatment. As shown previously (Baldwin, 1964) this
procedure is without any great effect oIn microsomal antigens and permits examina-
tion of antigenic components in the solubilized protein fractioni.
The top pattern in Fig. 5 shows the agar-gel cross-reaction pattern of deoxy-
cho'ate solubilized microsome fractions of normal liver (Nmic) and DMAB-
induced tumour (Tmic) with an anti-tumour microsome antiserum. Whilst the
agar gel precipitation reactions were much weaker than those obtained with cell
sap fractions, at least one tumour antigen not cross-reacting with normal liver
was detected. Furthermore, as shown in the lower pattern, this tumour antigen
did not cross-react with antigens in a microsomefraction prepared from apparentlv
normal liver taken from a tumour-bearing rat after 5 months' DMAB feeding
(NTLi.mic). This is interpreted as indicating that the abnormal tumour antigen
(lid not arise as a result ofsome non-specific response during DMAB carcinogenesis.
Altogether 12 deoxycholate solubilized microsome preparations, each of which
contained pooled tissue from 2 to 3 DMAB-induced tumours, have been examined
and in each case, at least one tumour antigen not cross-reacting with normal liver
was demonstrated. Abnormal microsomal antigen was also detected in two
tumours induced with 3'methyl-DMAB as well as in transplanted tumour. This
is illustrated in Fig. 6 which shows the agar gel cross-reaction pattern ofsolubilized
microsome fractions of normal liver (Nmic) and a third generation transplant of a
DMAB-induced tumour (D3mic) with anti-tumour microsome antiserum (anti-
Tmic). In this case, two antigens in the transplanted tumour were shown not to
cross-react with normal liver components.
Further confirmation of the presence of abnormal antigens in IDMAB-induced
liver tumour was provided by the analysis of anti-tumour microsome antiserum
l)re-absorbed with deoxycholate solubilized normal liver microsomes. Hence,
pre-absorptioni at 40 C. for 4 days with 1*5 mg. normal liver microsomal protein/ml.
anitiserum completely removed antibody reacting with this fraction. In contrast
the abnormal precipitation line detected with tumour microsomes was not removed
following absorption with up to 6 mg. liver microsomal protein/ml. antiserum.
Immunodiffusion patterns obtained using antiserum exhaustively absorbed with
normal liver microsomes were also much simpler and, as shown in Fig. 7, two
precipitation lines were detected following reaction with tumour microsomes
(Tmic) and these did not cross-react with normal liver microsomal antigens
(Nmic).
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The abnormal tumour microsomal antigens were more clearly defined by
immunoelectrophoretic analysis. Thus as shown in Fig. 8 (bottom pattern),
three major and at least three minor precipitation lines were detected following
reaction of solubilized tumour microsomes [Tmic (Doc. sol.)] with anti-tumour
microsome antiserum (anti-Tmic). In contrast, as shown in the top pattern, onlv
two components were detectable following reaction of the anti-tumour microsome
antiserum with normal liver microsomes [Nmic (Doc. Sol.)]. These two pre-
EXPLANATION OF PLATES.
FIG. 1.-Agar gel precipitation reaction of tissue cell sap fractions with rabbit antiserum pie-
pared against DMAB-induced liver tumour cell sap (anti-Tcs).
Ncs Normal liver cell sap.
NTLics-Cell sap fraction of liver taken from tumour-bearing rat.
Tcs DMAB-induced liver tumour cell sap.
All cell sap fractions contained 8-6 mg. protein/ml.
Fia. 2.-Cross-reactions in agar of cell sap fractions from normal liver and transp)lanted rat
tumours.
D8/4-4th generation transplant of tuinour D8.
D20/1 1st generation transplant of tumour D20.
Ncs Normal liver cell sap.
Anti-Tcs-Antiserum against primarv. DMAB-induced rat liver tumour.
Protein content of cell sap fractions 8-4 mg./ml.
FIG. 3. Immunodiffusion reactions of normal liver and liver tumour cell sap fractions (pro-
tein content 6-5 mg./ml) with anti-tumour cell sap antiserum absorbed with normal liver
cell sap (anti-Tcs, abs. Ncs).
(See Fig. 1 legend for key.)
FIr. 4. Immunoelectrophoresis of normal liver and tumour cell sap fractions (proteiiicontent
7-8 mg./ml.).
(See Fig. 1 legend for key.)
Fioe. 5. Agar gel cross-reaction patterns of deoxycholate solubilized microsome fraction with
anti-liver tumour microsome antiserum (anti-T mic).
N mic Normal liver microsomes.
T mic DMAB-induced tumour microsomes.
N.T.Li.mic Microsome fraction of liver taken from tumour bearing rat.
Protein content of microsome fractions, 6-7 mg./ml.
FIG. 6 -Agar gel precipitation patterns of deoxycholate solubilized microsome fractions of
normal liver (N.mic) and a 3rd generation transplant of a DMAB-induced tumour (D3mic)
with anti-tumour microsome antiserum (anti-T.mic). Protein content of microsome
fractions, 6 mg./ml.
FIG. 7. Immunodiffusion reactions of DMAB-induced tumour and normal liver microsome
fractions (deoxyeholate solubilized; protein content, 6 mg./ml.) with anti-tumour micro-
some antiserum pre-absorbed witb normal liver microsomes [anti-T.mic (abs.)].
(See Fig. 5 legend for key.)
FIG.. S. Immunoelectrophoresis of normal liver and DMAB-induced tumour microsome
fractions.
N.mic (Doc. sol.) Normal liver microsomes (3.2 mg. protein/ml.)
T.mic (Doc. sol.) DMAB-tumour microsomes (31$ mg. protein/ml.)
anti-T.mic anti-DMAB-tumour mnicrosome antiserumn.
anti-N.mic- anti-Normal liver microsome antiserum.
FIG. 9.-Immunoelectrophoresis of normal liver and tumour microsomes using anti-tumour
microsome antiserum pre-absorbed with normal liver microsomes [anti-T.mic (abs. with
N.mic)]. Protein content of microsome fractions, 5-6 mg./ml.
(See Fig. 8 legend for key.)
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cipitation lines were also demonstrable following reaction of the tumour frac-
tion with anti-normal liver microsome antiserum (anti-Nmic; centre reaction)
further indicating that these lines are formed by antigens common to both normal
liver and tumour. The centre reactions of microsome fractions with anti-normal
liver microsome antiserum also demonstrate the concurrent loss of normal liver
antigens from tumour.
Although the immunoelectrophoretic patterns obtained with anti-tumour
microsome antisera exhaustively absorbed with normal liver microsomes were
much weaker, abnormal tumour components were more easily detected, and as
shownin Fig. 9,four precipitationlineswere formedfollowingreaction with tumour
microsomes whereas no reaction was detected with normal liver.
DISCUSSION
The present studies demonstrate that DMAB-induced rat liver tumours
contain microsomal and cell sap antigens which are not detectable in normal liver.
The absence of these antigens from liver taken from tumour-bearing rats also
indicates that they arise during tumour induction and not as a non-specific
response, such as cell population changes, during carcinogen feeding in the low
protein diet. Furthermore, the finding that antibody reacting with the abnormal
tumour microsome and cell sap antigens cannot be removed by exhaustive
absorption of anti-tumour antiserum with normal liver fractions indicates that
these antigens are not normal liver components present in greatly increased
amounts. Thus for example, under the conditions used for pre-absorption of
anti-tumour cell sap antiserum with normal liver, for the abnormal precipitation
lines detected in tumour to be due to normal liver antigens, these components
would need to be elevated at least 200-fold.
Abnormal microsomal antigens in transplanted rat hepatomas originally
induced with DMAB have also been demonstrated using immunodiffusion methods
by Maisin (1964) and Deckers (1964). In these studies, the abnormal microsomal
antigens were shown to be specific for each tumour line and there was no evidence
of cross-reactivity with antigens in other primary or transplanted rat hepatomas.
These results contrast with present findings where common microsomal antigens
were demonstrated in primary tumours. This may be due to the use of antisera
prepared against pooled microsome fractions from DMAB-induced liver tumours
so that only common antigens would be detected whilst individual differences
were obscured. Additionally, however, the tumours used by Maisin and Deckers
had undergone repeated transplantation and this may have resulted in some
antigenic simplification. In current studies (Baldwin and Barker, 1964) using
antisera prepared against microsome fractions from two transplanted liver
tumours it has been shown that each tumour possesses specific, non-cross-reacting
antigens. In addition there were, however, common microsomal antigens not
detectable in normal liver.
Previous studies on cell antigen changes during liver carcinogenesis have been
restricted almost exclusively to microsomal antigens and little attention has been
paid to antigens in other sub-cellular fractions. The present studies indicate that
significant changes also occur in the soluble cytoplasmic protein fraction and a
number of tumour antigens not detectable in normal or DMAB-treated rat liver
were demonstrated. These findings are comparable with recent studies demon-
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strating abnormal soluble antigens in human tumours (Itakura, 1963; McKenna,
Sanderson and Blakemore, 1964; Tee, Wang and Watkins, 1964) whilst Hirai,
Taga, Isaka, Satoh and Warabioka (1963) isolated a soluble tumour antigen from
a rat ascites hepatoma.
Whilst the present findings indicate that DMAB-induced liver tumours contain
a number of cell sap and microsomal antigens not detectable in normal or carcino-
gen-treated rat liver, these antigens are not necessarily tumour specific. Hence
it has been demonstrated (Baldwin and Barker, 1964) that one tumour microsomal
antigen cross-reacts with acomponent in normal lung microsomes. Furthermore,
one tumour cell sap antigen was detected in normal rat kidney whilst another was
demonstrable in newborn rat serum. This latter component is probably the
embryonala-globulin detected in transplanted mouse and rat hepatomas (Abelev,
Perova, Khramkova, Postnikova and Irlin, 1963). Similarly Day (1965) has
also reported that one of the antigens detected in 2-acetamidofluorene induced
hepatomas was shared with kidney and spleen but not liver. Clearly these cross-
reacting antigens are not tumour specific, but they may be an expression, either
quantitatively or qualitively, of the de-differentiation of liver cells during carcino-
genesis.
Presently available evidence indicates that certain tumour microsomal and
cell sap antigens do not cross-react with components in normal rat tissues.
Further, more unequivocal evidence that DMAB-induced liver tumours contain
tumour-specific antigens has been provided by the demonstration of induced
immunity against tumours transplanted into syngeneic recipients (Baldwin and
Barker, 1964). The relationship of the abnormal antigens detected in the present
study to those responsible for the induction of tumour immunity is now under
investigation.
Theorigin ofthe abnormal antigens in DMAB-induced liver tumour is unknown
and there is no evidence indicating whether or not they are involved in the
carcinogenic process. Modified tissue antigens have been demonstrated during
the early stages of DMAB-carcinogenesis (Baldwin, 1962). These antigens also
reacted with rabbit antisera prepared against synthetic bovine serum albumin-
DMAB conjugates (Baldwin, Beswick, Chayen and Cunningham, 1960), indicating
the presence of aminoazo dye prosthetic groups and this suggests that they are
normal liver proteins modified as a result of covalent binding with DMAB meta-
bolites. There is no evidence, however, that these antigens bear any relationship
to the abnormal tumour components and it has been shown that there is little or
no bound carcinogen in tumour (Miller and Miller, 1953). The finding that
abnormal antigens are present in transplanted tumour further indicates that they
are unlikely to have arisen through direct interaction of carcinogen metabolites
with cellular components in tumour. Similar results have been reported by
Korosteleva (1957) who demonstrated abnormal antigens in liver from o-amino-
azotoluene treated mice which showed some reactivity to the carcinogen, whilst
these antigens were absent from induced tumour.
A more attractive postulate is that tumour antigens arise through the specific
action of DMAB on some self-reproducing template since this could alko explain
the loss ofnormalliver cellsapandmicrosomalantigensfromtheemergent tumour
(Baldwin, 1964). Asyet, however, there is no evidence to indicate whether these
antigenic changes, either by gain or loss, are causally connected with neoplastic
transformation or are simply alternative expressions of biochemical modification.
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Thus cell antigen changes may simply reflect multiple mutational changes induced
by the carcinogen. The data so far obtained is not sufficiently precise to indicate
whether the abnormal tumour antigens can be equated with the deleted normal
liver components. Nevertheless, Fig. 8 illustrates that the abnormal tumour
microsomal antigens have comparable electrophoretic mobilities to the deleted
normal liver microsomal antigens.
The present studies indicate that DMAB-induced liver tumours contain
abnormal cell antigens and it has been shown also (Baldwin, 1963) that at least
some ofthese antigens are present in the serum from tumour-bearing rats. These
antigens are probably released following cell damage during carcinogen feeding
and so should be available for the induction of an immune response in the host.
Although recent studies (Baldwin and Barker, 1964) have shown that immunity
can be induced against these tumours when transplanted into suitably pre-treated
isogeneic hosts, no evidence has yet been obtained of any immune mechanisms
operating during DMAB carcinogenesis. Nor, so far, has it been possible to
demonstrate circulating anti-tumour antibody at any stage of carcinogen feeding.
However, Maisin (1964b) has reported that immunization with rat hepatoma
microsomes conferred some resistance to the carcinogenic action of DMAB.
Since it has been shown (Baldwin, unpublished observations) that cell bound
antibody is involved in immunity to transplanted rat liver tumours, the possibility
that this type ofimmune response develops in the rat during DMAB carcinogenesis
is now being investigated.
SUMMARY
Aminoazo-dye-induced rat liver tumours have been shown to contain a number
of common microsomal and cell sap antigens which were not detectable in normal
liver. The absence ofthese antigens fromDMAB-treated livertakenfrom tumour-
bearing rats demonstrated that they arose during tumour induction and not as a
result of a non-specific response during carcinogen feeding. Absorption studies
also indicated that they were not normal liver antigens present in tumour in
greatly increased concentration.
The significance of the tumour antigens in aminoazo dye carcinogenesis is
discussed together with the previous findings of antigen deletion. Furthermore,
the possibility is considered that an immune response may be evoked against
these antigens during DMAB carcinogenesis.
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